These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23894069)

  • 1. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
    Yu HC; Tsai WC; Kung PT
    Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: a national cohort study.
    Chou CW; Kung PT; Chou WY; Tsai WC
    BMJ Open; 2019 Oct; 9(10):e026626. PubMed ID: 31619415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
    Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
    Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
    Chen CC; Cheng SH
    Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
    Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
    Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pay for performance on risk incidence of hip fracture in type 2 diabetic patients: a nationwide population-based cohort study.
    Lee YH; Kung PT; Kuo WY; Kao SL; Tsai WC
    Medicine (Baltimore); 2020 Mar; 99(12):e19592. PubMed ID: 32195973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Diabetes Pay-for-Performance Program and Risks of Cancer Incidence and Death in Patients With Type 2 Diabetes in Taiwan.
    Hsieh HM; He JS; Shin SJ; Chiu HC; Lee CT
    Prev Chronic Dis; 2017 Oct; 14():E88. PubMed ID: 28981404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions?
    Huang YC; Lee MC; Chou YJ; Huang N
    Med Care; 2016 Nov; 54(11):977-983. PubMed ID: 27547944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pay-for-performance program on infection events and mortality rate in diabetic patients: a nationwide population-based cohort study.
    Wu YF; Chen MY; Chen TH; Wang PC; Peng YS; Lin MS
    BMC Health Serv Res; 2021 Jan; 21(1):78. PubMed ID: 33478477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does enhanced diabetes management reduce the risk and improve the outcome of tuberculosis?
    Lo HY; Yang SL; Lin HH; Bai KJ; Lee JJ; Lee TI; Chiang CY
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):376-82. PubMed ID: 27046720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A diabetes pay-for-performance program and the competing causes of death among cancer survivors with type 2 diabetes in Taiwan.
    Hsieh HM; Chiu HC; Lin YT; Shin SJ
    Int J Qual Health Care; 2017 Aug; 29(4):512-520. PubMed ID: 28531317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pay for performance on risk incidence of infection and of revision after total knee arthroplasty in type 2 diabetic patients: A nationwide matched cohort study.
    Tsai YS; Kung PT; Ku MC; Wang YH; Tsai WC
    PLoS One; 2018; 13(11):e0206797. PubMed ID: 30388167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of diabetes pay-for-performance incentive designs.
    Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
    Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of pay-for-performance on mortality in diabetes patients in Taiwan: A population-based study.
    Chen YC; Lee CT; Lin BJ; Chang YY; Shi HY
    Medicine (Baltimore); 2016 Jul; 95(27):e4197. PubMed ID: 27399144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient and provider factors associated with enrolment in the pre-end-stage renal disease pay-for-performance programme in Taiwan: a cross-sectional study.
    Hu HY; Jian FX; Lai YJ; Yen YF; Huang N; Hwang SJ
    BMJ Open; 2019 Sep; 9(9):e031354. PubMed ID: 31519682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcomes of the pay-for-performance program for patients with young-onset (20-40 years of age) type 2 diabetes.
    Yen FS; Cheng-Chung Wei J; Hung YT; Hsu CC; Hwu CM
    Diabetes Res Clin Pract; 2022 Nov; 193():110136. PubMed ID: 36341981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing trend in emergency department visits for hypoglycemia from patients with type 2 diabetes mellitus in Taiwan.
    Chen YJ; Yang CC; Huang LC; Chen L; Hwu CM
    Prim Care Diabetes; 2015 Dec; 9(6):490-6. PubMed ID: 25937182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of pay-for-performance on tuberculosis treatment in Taiwan.
    Li YH; Tsai WC; Khan M; Yang WT; Lee TF; Wu YC; Kung PT
    Health Policy Plan; 2010 Jul; 25(4):334-41. PubMed ID: 20207703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding Pay-for-Performance Program to Routine Care Was Related to a Lower Risk of Depression Among Type 2 Diabetes Patients in Taiwan.
    Lian WC; Livneh H; Huang HJ; Lu MC; Guo HR; Tsai TY
    Front Public Health; 2021; 9():650452. PubMed ID: 34722429
    [No Abstract]   [Full Text] [Related]  

  • 20. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
    Tan EC; Pwu RF; Chen DR; Yang MC
    Qual Life Res; 2014 Mar; 23(2):687-96. PubMed ID: 23975377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.